First Eagle Investment Management’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

First Eagle Investment Management’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-180,899	Closed	-$362K	–	334
2015 Q1	$362K	Hold	180,899	–	–	﹤0.01%	256
2014 Q4	$190K	Buy	+180,899	New	+$196K	﹤0.01%	272

Other funds holding BTX.WS

ICM

Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PCA

Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BAMS

Bellevue Asset Management (Switzerland) Kuesnacht, Switzerland $656M AUM 11.45% 1-Year Est. Return

First Eagle Investment Management's BTX.WS Position: Q2 2015 in Review

First Eagle Investment Management sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q2 2015, closing a stake of 180,899 shares — an estimated $362K sold.

First Eagle Investment Management first reported a position in BTX.WS in Q4 2014 and held it in 2 quarters. The position peaked at $362K in Q1 2015. 37 funds tracked by Wall St. Rank hold BTX.WS as of Q2 2015.

First Eagle Investment Management reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q2 2015 after selling out during the quarter.
First Eagle Investment Management sold 180,899 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q2 2015, an estimated $362K.
First Eagle Investment Management first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 2 quarters.
First Eagle Investment Management's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $362K in Q1 2015.
37 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q2 2015.

Based on First Eagle Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.